Welcome to our dedicated page for Cardinal Health SEC filings (Ticker: CAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cardinal Health, Inc. (NYSE: CAH) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Cardinal Health is an Ohio corporation whose common shares trade on the New York Stock Exchange under the symbol CAH, as noted in multiple Form 8-K filings. These documents give investors detailed insight into the company’s financial condition, governance, capital structure, and material events.
Cardinal Health regularly files Form 8-K current reports to announce significant developments. Recent 8-K filings include disclosures about quarterly and annual financial results, updates to fiscal 2026 non-GAAP earnings per share outlook, entry into material definitive agreements such as credit facilities and receivables purchase amendments, public offerings of notes to help fund acquisitions like Solaris Health, and the completion of those offerings. Other 8-Ks document matters such as the 2025 Annual Meeting of Shareholders and voting results on director elections, say-on-pay, and auditor ratification.
The company’s definitive proxy statement on Schedule 14A (DEF 14A) offers extensive information on corporate governance, Board composition, executive compensation, and shareholder voting items. Cardinal Health’s proxy materials describe its strategic priorities, fiscal performance highlights, Board skills and refreshment, and engagement with shareholders.
Through Stock Titan, users can review Cardinal Health’s periodic and current reports and use AI-powered tools to summarize key points from lengthy filings. These tools help explain complex sections, highlight items such as non-GAAP metrics definitions, capital markets transactions, and credit agreements, and make it easier to track themes like Specialty growth, distribution network investments, and capital allocation. The filings page also surfaces relevant exhibits, including indentures, underwriting agreements, and amendments to financing arrangements, giving a structured view of Cardinal Health’s obligations and governance framework.
Cardinal Health insider filed a Form 144 to sell 25,151 shares of Common stock on or about 08/19/2025 with an aggregate market value of $4,192,926 and the shares are to be sold on the NYSE. The filing shows the securities were acquired through company grants that vested: one grant vested 06/30/2025 (5,322 shares) and two grants keyed to 08/15/2025 (5,285 restricted shares and 17,544 performance shares). The filer certifies no undisclosed material information.
Note: the filing tables list acquisition rows that sum to 28,151 shares while the notice states 25,151 shares to be sold, which is an inconsistency present in the document.
Cardinal Health (CAH) Form 144 notice reports a proposed sale of 38,078 common shares through Merrill Lynch on the NYSE with an aggregate market value of $5,666,934.00, and approximately 238,793,647 shares outstanding. The securities to be sold were acquired mostly through performance unit vesting and restricted stock vesting on dates between November 15, 2022 and August 15, 2025, with specific lots of 18,500; 5,160; 5,300; 4,955; and 4,163 shares listed. The filer certifies no undisclosed material adverse information and provides a notice date and signature block as required by Rule 144.
Form 144 notice from Cardinal Health, Inc. (CAH) discloses a proposed sale of 41,575 common shares through Merrill Lynch on the NYSE with an aggregate market value reported as $6,186,923 and an approximate sale date of 08/19/2025. The securities being offered were acquired by the selling person through vesting events: performance stock vesting (30,077 shares on 08/15/2025 and 3,692 shares on 06/30/2025) and restricted stock vesting (7,806 shares on 08/15/2025). The filer certifies no undisclosed material adverse information and indicates no sales by the person in the past three months.
Cardinal Health (CAH) Form 144 notice reports a proposed sale of 5,373 common shares through The Charles Schwab Corporation on the NYSE with an aggregate market value of $795,204.00. The filer acquired the shares as restricted stock units on 08/16/2024 (3,050 shares) and 02/15/2025 (2,323 shares). The filing states there were 238,793,647 shares outstanding and lists the approximate sale date as 08/19/2025. No securities were reported sold by the filer in the past three months, and no gifts or noncash payments are indicated.
Cardinal Health Form 144 notice: The filing reports a proposed sale of 13,500 shares of common stock through Merrill (Columbus, OH) with an aggregate market value of $2,009,030NYSE and total shares outstanding are reported as 238,793,647. The approximate sale date is 08/19/2025. The shares to be sold were acquired mostly on 08/15/2025 as restricted and performance stock vesting (3,863 restricted; 9,318 performance) and a smaller tranche on 02/15/2025 (319 restricted).
The filer certifies there are no undisclosed material adverse facts and notes no sales in the past three months. This is a routine insider sale notice required under Rule 144 describing the broker, quantity, acquisition dates and nature of acquisition.
Cardinal Health, Inc. announced the sale of $1.0 billion of senior notes: $600,000,000 of 4.500% Notes due 2030 and $400,000,000 of 5.150% Notes due 2035, under an effective Form S-3ASR registration statement. The offering was made through an underwriting agreement dated August 13, 2025, with Goldman Sachs & Co. LLC, BofA Securities, Inc., and Wells Fargo Securities, LLC serving as representatives of the underwriters. The disclosure references the registration statement number and notes that the cover page interactive data file is embedded in the Inline XBRL document. The Form 8-K is signed by Aaron E. Alt, Chief Financial Officer, and dated August 14, 2025.
Michelle D. Greene, Chief Information Officer of Cardinal Health, Inc. (CAH), filed a Form 4 reporting a securities transaction dated 08/12/2025. The filing lists transactions in common shares tied to performance share units, shows a reported quantity of 16,362 (marked with an "A") and another listed amount of 34,968 (marked with a "D"); the row shows a price of $0. The explanatory note states these are performance share units that will settle on August 15, 2025.
The form was signed by James E. Barnett, Attorney-in-fact on 08/12/2025. The filing identifies Greene's title and gives a reporting address in Dublin, Ohio. The document does not provide total outstanding shares or percent ownership, so materiality relative to the company-wide share count cannot be determined from this filing alone.
Deborah Weitzman, an officer listed as "CEO, PSS Segment" at Cardinal Health (CAH), was recorded as acquiring 39,100 performance share units on 08/12/2025 that are scheduled to settle on August 15, 2025.
The award is reported at a $0 price and is described as performance share units that will settle to common shares on the stated settlement date. After the reported acquisition, Ms. Weitzman’s beneficial ownership is shown as 88,229 common shares held directly. The filing shows this transaction as an acquisition (code A) and Table II reports no derivative securities.
Form 4 disclosure from Cardinal Health, Inc. (CAH) reports that Snow Ola M, the companys Chief Human Resources Officer, filed a change in beneficial ownership on 08/12/2025. The filing documents transactions in common shares tied to performance-based awards and is marked as a filing by one reporting person.
The tabular section lists the numeric entries 31,813 and 55,351 and shows a price of $0. The filing explicitly states these figures reflect performance share units that will settle on August 15, 2025. The form is signed by /s/ James E. Barnett, Attorney-in-fact dated 08/12/2025.
Cardinal Health insider transaction summary: Mary C. Scherer, listed as Chief Accounting Officer and reporting person for Cardinal Health, reported an acquisition of 3,029 common shares recorded as performance share units tied to the issuer. The transaction date is listed as 08/12/2025 and the filing states these performance share units will settle on August 15, 2025. Following the reported transaction the filing shows 11,691 common shares beneficially owned by the reporting person. The entry lists a $0 price, consistent with compensation-settled awards. This filing records a routine equity award rather than an open-market purchase or sale.
FAQ
What is the current stock price of Cardinal Health (CAH)?
What is the market cap of Cardinal Health (CAH)?
